BIO-RAD LABORATORIES, INC. BIO Income Statement

Bio-rad laboratories, inc. (BIO)

Income statement / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Mar'10	Sep'09	Jun'09
Net sales
571,600	624,459	560,600	572,600	554,000	616,915	545,100	575,900	551,500	621,295	534,141	504,666	500,051	571,453	508,745	516,777	471,197	570,557	469,961	506,102	472,821	598,224	530,644	536,832	509,344	602,635	505,066	525,321	499,672	573,839	498,697	510,422	486,277	550,238	516,514	521,656	485,121	533,720	471,502	467,662	454,234	461,055	427,183
Cost of goods sold
254,276	293,989	253,607	264,850	242,217	284,282	258,422	274,244	249,316	276,038	235,133	231,291	229,988	256,755	229,276	236,545	207,168	262,042	206,509	226,505	202,715	280,814	242,068	239,590	234,055	279,886	220,850	225,220	228,260	258,933	224,927	222,522	207,695	238,332	220,338	228,520	207,510	233,997	205,172	199,354	197,107	200,545	185,221
Gross profit
317,368	330,439	307,026	307,769	311,762	332,565	286,716	301,667	302,203	345,257	299,008	273,375	270,063	314,698	279,469	280,232	264,029	308,515	263,452	279,597	270,106	317,410	288,576	297,242	275,289	322,749	284,216	300,101	271,412	314,906	273,770	287,900	278,582	311,906	296,176	293,136	277,611	299,723	266,330	268,308	257,127	260,510	241,962
Selling, general and administrative expense
193,692	214,165	201,622	201,257	207,581	214,032	201,196	210,425	209,130	201,730	198,169	212,489	194,402	217,993	201,452	205,536	189,716	193,145	187,445	192,845	188,555	207,537	202,550	195,838	202,275	214,584	202,238	195,331	185,917	188,095	160,134	162,256	171,293	174,614	176,867	176,740	167,763	176,672	148,654	156,270	153,617	153,623	143,670
Research and Development Expense
49,303	57,069	47,944	50,122	47,575	53,074	49,245	47,450	49,427	76,041	62,077	62,587	49,452	57,387	49,924	49,811	48,586	55,887	43,336	46,547	47,202	59,287	52,786	55,717	52,543	55,848	52,920	51,841	50,343	56,150	47,795	52,336	52,923	41,277	45,387	48,210	42,730	45,267	42,874	43,862	40,263	39,516	42,407
Impairment losses on goodwill and long-lived assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	2,360	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Segment profit (loss)
74,373	59,205	57,460	56,390	56,606	-227,054	36,275	43,792	43,646	55,980	38,762	-1,701	26,209	-20,627	28,093	22,525	25,727	59,483	32,671	40,205	34,349	50,586	33,240	45,687	20,471	52,317	29,058	52,929	35,152	70,661	65,841	73,308	54,366	96,015	73,922	68,186	67,118	77,784	74,802	68,176	63,247	67,371	55,885
Interest expense
5,690	6,064	5,525	5,841	5,986	6,139	6,064	5,977	5,782	5,781	5,872	6,045	5,316	6,534	5,634	5,632	5,580	6,034	5,822	4,834	5,002	5,000	7,710	5,564	3,857	7,019	31,611	11,664	10,977	13,614	11,901	12,401	13,196	11,987	12,341	12,041	16,766	20,548	14,400	14,325	14,444	14,487	10,367
Foreign exchange (gains) losses, net
-928	1,166	-898	-1,233	-1,280	-950	-672	15	-1,254	-1,460	-3,363	-2,516	-1,789	-966	-1,210	-1,237	-1,129	-1,339	-2,166	-2,938	-3,806	-3,187	-3,667	286	-2,737	-2,843	-3,330	-865	-1,528	-1,532	-448	-1,619	-1,441	-1,710	-6,346	-2,744	-3,042	96	-2,749	-1,014	-217	1,472	2,551
Marketable Securities, Unrealized Gain (Loss)
827,671	645,988	-390,620	716,389	1,059,230	-814,109	318,007	286,398	815,934	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Nonoperating Income (Expense)
3,300	-900	4,400	3,900	18,700	7,000	2,600	15,900	11,100	-2,786	1,061	11,382	1,043	-24	1,439	11,208	1,177	2,088	732	7,107	1,153	3,347	613	8,388	661	2,055	667	8,644	1,400	7,191	1,511	6,731	6,450	1,676	538	4,418	951	1,901	256	2,517	-799	192	-6,307
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest
898,700	699,400	-335,200	769,600	1,127,300	-1,041,200	350,100	340,100	863,700	45,945	30,588	1,120	20,147	-28,147	22,688	26,864	20,195	54,198	25,415	39,540	26,694	45,746	22,476	48,797	14,538	44,510	-5,216	49,044	24,047	62,706	55,003	66,019	46,179	83,994	55,773	57,819	48,261	57,201	57,909	55,354	49,819	51,220	49,274
(Provision) benefit for income taxes
212,787	145,938	-76,400	170,791	262,071	-212,763	80,805	72,043	206,915	-36,740	8,521	-3,915	7,734	-5,452	4,283	8,850	7,919	8,570	8,045	11,117	8,876	6,709	10,967	17,166	7,870	14,374	1,883	14,442	3,875	19,289	12,383	17,454	15,235	24,003	9,911	17,797	15,323	-10,736	12,824	16,833	14,427	11,920	-9,974
Net income including noncontrolling interests
-	-	-	-	-	-	-	-	-	-	-	-	-	-	18,405	18,014	12,276	-	17,370	28,423	17,818	-	11,509	31,631	6,668	30,136	-7,099	34,602	20,172	43,417	42,620	48,565	30,944	59,991	45,862	40,022	32,938	67,937	45,085	38,521	35,392	39,300	39,300
Net loss (income) attributable to noncontrolling interests
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	21	-79	-13	222	-61	-38	-35	-26	-101	29	321	564	531	776	-1,331
Net Income (Loss) Attributable to Parent
685,900	553,506	-258,816	598,810	865,200	-828,569	269,326	268,043	656,800	82,685	22,067	5,035	12,413	-22,695	18,405	18,014	12,276	45,628	17,370	28,423	17,818	39,037	11,509	31,631	6,668	30,136	-7,099	34,602	20,151	43,496	42,633	48,343	31,005	60,029	45,897	40,048	33,039	67,908	44,764	37,957	34,861	38,524	37,969
Basic earnings per share:
Net income per share basic attributable to Bio-Rad
22.97	18.50	-8.68	20.08	29.03	-27.81	9.02	8.99	22.05	2.79	0.74	0.17	0.42	-0.78	0.63	0.61	0.42	1.56	0.59	0.98	0.61	1.35	0.40	1.10	0.23	1.05	-0.25	1.21	0.71	1.53	1.51	1.71	1.10	2.15	1.63	1.43	1.18	2.44	1.62	1.37	1.27	1.40	1.39
Weighted Average Number of Shares Outstanding, Basic
29,865	29,926	29,831	29,814	29,801	29,880	29,863	29,814	29,787	29,767	29,660	29,613	29,580	29,554	29,444	29,398	29,364	29,321	29,195	29,136	29,092	29,003	28,884	28,826	28,791	28,709	28,603	28,538	28,494	28,397	28,312	28,250	28,201	28,134	28,072	28,014	27,904	27,812	27,697	27,606	27,545	27,431	27,370
Diluted earnings per share:
Net income per share diluted attributable to Bio-Rad
22.72	18.35	-8.68	19.86	28.74	-27.43	8.89	8.87	21.77	2.76	0.73	0.17	0.41	-0.77	0.62	0.61	0.42	1.54	0.59	0.97	0.61	1.34	0.39	1.09	0.23	1.04	-0.25	1.20	0.70	1.51	1.49	1.69	1.09	2.11	1.61	1.41	1.16	2.41	1.59	1.35	1.24	1.38	1.37
Weighted Average Number of Shares Outstanding, Diluted
30,196	30,647	29,831	30,154	30,104	30,230	30,292	30,219	30,171	30,167	30,052	30,006	29,911	29,818	29,671	29,589	29,506	29,527	29,439	29,381	29,289	29,240	29,141	29,092	29,059	29,336	28,603	28,868	28,817	28,760	28,645	28,610	28,553	28,532	28,456	28,495	28,389	28,304	28,103	28,125	28,072	27,875	27,742